Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Journal of Immunological Methods|October 31, 2001
Whole cell ELISA for detection of tumor antigen expression in tumor samplesL F Erdile, D Smith, D BerdSeminars in Oncology|June 1, 1986
The immunoaugmenting effects of cancer chemotherapeutic agentsM J Mastrangelo, D Berd, H MaguireCancer Treatment Reports|September 1, 1977
Combination therapy for diffuse histiocytic lymphoma that includes antimetabolitesE Cadman, L Farber, D Berd, et al.Cancer Research|May 1, 1986
Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamideD Berd, H C Maguire, M J MastrangeloCancer Research|November 1, 1984
Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamideD Berd, H C Maguire, M J MastrangeloCancer Research|March 1, 1984
Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancerD Berd, H C Maguire, M J MastrangeloThe Journal of Investigative Dermatology|March 1, 1993
Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapyG F Murphy, A Radu, M Kaminer, et al.Cancer Research|December 1, 1989
Flow cytometric determination of the frequency and heterogeneity of expression of human melanoma-associated antigensD Berd, M Herlyn, H Koprowski, et al.Clinical Immunology and Immunopathology|January 1, 1995
Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccineT Sato, H C Maguire, M J Mastrangelo, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1994
Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccineD Berd, H C Maguire, M J Mastrangelo, et al.Pageof 6